The financial burden and distress of patients with cancer: understanding and stepping‐up action on the financial toxicity of cancer treatment PM Carrera, HM Kantarjian, VS Blinder CA: a cancer journal for clinicians 68 (2), 153-165, 2018 | 782 | 2018 |
Measuring financial toxicity as a clinically relevant patient‐reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST) JA De Souza, BJ Yap, K Wroblewski, V Blinder, FS Araújo, FJ Hlubocky, ... Cancer 123 (3), 476-484, 2017 | 694 | 2017 |
American Society of Clinical Oncology position statement: strategies for reducing cancer health disparities among sexual and gender minority populations J Griggs, S Maingi, V Blinder, N Denduluri, AA Khorana, L Norton, ... Journal of Clinical Oncology 35 (19), 2203-2208, 2017 | 254 | 2017 |
Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial E Basch, D Schrag, S Henson, J Jansen, B Ginos, AM Stover, P Carr, ... Jama 327 (24), 2413-2422, 2022 | 186 | 2022 |
A review of cancer in US Hispanic populations RW Haile, EM John, AJ Levine, VK Cortessis, JB Unger, M Gonzales, ... Cancer Prevention Research 5 (2), 150-163, 2012 | 126 | 2012 |
Impact of cancer on employment VS Blinder, FM Gany Journal of Clinical Oncology 38 (4), 302, 2020 | 118 | 2020 |
Return to work in low‐income Latina and non‐Latina white breast cancer survivors: a 3‐year longitudinal study VS Blinder, S Patil, A Thind, A Diamant, CA Hudis, E Basch, RC Maly Cancer 118 (6), 1664-1674, 2012 | 112 | 2012 |
Women with breast cancer who work for accommodating employers more likely to retain jobs after treatment V Blinder, C Eberle, S Patil, FM Gany, CJ Bradley Health Affairs 36 (2), 274-281, 2017 | 103 | 2017 |
Predictors of unemployment after breast cancer surgery: a systematic review and meta-analysis of observational studies L Wang, BY Hong, SA Kennedy, Y Chang, CJ Hong, S Craigie, HY Kwon, ... Journal of clinical oncology 36 (18), 1868-1879, 2018 | 101 | 2018 |
A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer … T Bao, AD Seidman, L Piulson, E Vertosick, X Chen, AJ Vickers, ... European Journal of Cancer 101, 12-19, 2018 | 100 | 2018 |
Updated standardized definitions for efficacy end points (STEEP) in adjuvant breast cancer clinical trials: STEEP version 2.0 SM Tolaney, E Garrett-Mayer, J White, VS Blinder, JC Foster, ... Journal of Clinical Oncology 39 (24), 2720-2731, 2021 | 99 | 2021 |
Employment after a breast cancer diagnosis: a qualitative study of ethnically diverse urban women VS Blinder, MM Murphy, LT Vahdat, HT Gold, I de Melo-Martin, MK Hayes, ... Journal of community health 37, 763-772, 2012 | 97 | 2012 |
Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer HT Gold, MJ Hall, V Blinder, BR Schackman Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 87 | 2009 |
Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study V Blinder, S Patil, C Eberle, J Griggs, RC Maly Breast cancer research and treatment 140, 407-416, 2013 | 76 | 2013 |
Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis AK Green, EM Aviki, K Matsoukas, S Patil, D Korenstein, V Blinder Breast cancer research and treatment 172, 247-263, 2018 | 74 | 2018 |
A pilot randomized controlled trial of cognitive bias modification to reduce fear of breast cancer recurrence WG Lichtenthal, GW Corner, ET Slivjak, KE Roberts, Y Li, W Breitbart, ... Cancer 123 (8), 1424-1433, 2017 | 73 | 2017 |
Physician-driven variation in nonrecommended services among older adults diagnosed with cancer A Lipitz-Snyderman, CS Sima, CL Atoria, EB Elkin, C Anderson, V Blinder, ... JAMA internal medicine 176 (10), 1541-1548, 2016 | 63 | 2016 |
Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program VS Blinder, VW Norris, NW Peacock, JJ Griggs, DP Harrington, A Moore, ... Cancer 119 (1), 164-172, 2013 | 57 | 2013 |
The role of environmental factors in the etiology of lymphoma V Blinder, SG Fisher Cancer investigation 26 (3), 306-316, 2008 | 50 | 2008 |
Immunomodulatory activity of a colony-stimulating factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: a phase I study KA Autio, CA Klebanoff, D Schaer, JSW Kauh, SF Slovin, M Adamow, ... Clinical Cancer Research 26 (21), 5609-5620, 2020 | 48 | 2020 |